Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation

Hugh Calkins; Matias Nordaby

doi:10.1056/NEJMc1707247

Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation

Hugh Calkins
, Matias Nordaby

School of Medicine

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	494-496
Number of pages	3
Journal	New England Journal of Medicine
Volume	377
Issue number	5
DOIs	https://doi.org/10.1056/NEJMc1707247
State	Published - Aug 3 2017

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc1707247

Cite this

@article{62aeea0c90484a8baa99f0491e3b7b64,

title = "Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation",

author = "Hugh Calkins and Matias Nordaby",

year = "2017",

month = aug,

day = "3",

doi = "10.1056/NEJMc1707247",

language = "English (US)",

volume = "377",

pages = "494--496",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "5",

}

TY - JOUR

T1 - Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation

AU - Calkins, Hugh

AU - Nordaby, Matias

PY - 2017/8/3

Y1 - 2017/8/3

UR - https://www.scopus.com/pages/publications/85044519892

UR - https://www.scopus.com/pages/publications/85044519892#tab=citedBy

U2 - 10.1056/NEJMc1707247

DO - 10.1056/NEJMc1707247

M3 - Letter

C2 - 28767343

AN - SCOPUS:85044519892

SN - 0028-4793

VL - 377

SP - 494

EP - 496

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 5

ER -

Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this